The NAT2 gene helps the liver process certain medicines and chemicals, including some used to treat infections. Differences in this gene can help explain why people break down the same drug at different speeds. If you carry a slower working NAT2 variant, some medicines may stay in the body longer and side effects may be more likely. In medicine, NAT2 is best known for shaping your acetylator type, which is a label for how quickly your body handles certain drugs such as isoniazid.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or guide activities in the body. Some genes provide the directions for producing proteins, which do much of the work inside cells. Others mainly regulate when certain activities happen, where they take place, and how active they are. Together, genes affect how the body grows and works, and they can also influence how you react to food, stress, and medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
NAT2Gene function
What if the gene works
The NAT2 gene helps your liver process and clear some medicines and other chemicals. This supports how your body handles substances from tobacco smoke, diet, and the environment.
Risk
What if the gene does not work
Changes in the NAT2 gene can reduce how well cells add acetyl groups, a small chemical tag, to certain compounds. Effects range from milder to more severe variants, leading to slower or sometimes absent NAT2 enzyme activity.
Treatment
What does that mean for your treatment
Loss-of-function variants in the NAT2 gene can slow isoniazid breakdown, so standard treatment may lead to higher drug levels and a greater chance of liver or nerve side effects. Current pharmacogenetic guidelines use NAT2 acetylator status to help tailor isoniazid dosing, while people with rapid NAT2 activity may clear the drug faster and may respond differently.
Gene function
What if the gene works
Your body uses the NAT2 gene to help handle certain medicines and everyday chemicals. It is most active in the liver and also works in the gut, where many substances are changed before they leave the body. Understanding how the NAT2 gene works can make it easier to see how your body processes some medicines and other chemicals.
The NAT2 gene makes an enzyme that adds a small chemical tag called an acetyl group to certain compounds. This step changes how the body handles those substances and often prepares them for the next stage of processing.
This gene helps process a group of medicines and other compounds known as arylamines and hydrazines. By modifying these substances, it supports the body’s normal way of handling chemicals that come from outside the body.
Its enzyme is especially active in the liver and the lining of the gut, where many swallowed substances are handled early. That timing helps your body start processing some chemicals soon after they are absorbed.
After its enzyme changes a compound, that substance may become easier for the body to move, break down further, or clear. This supports a steady, routine cleanup process.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help make up normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NAT2 gene often change the NAT2 enzyme’s shape, stability, or activity, which helps explain how NAT2 gene variants affect acetylation inside cells. Some changes only partly lower enzyme function, while others reduce it much more, creating slow, intermediate, or rapid acetylator patterns. More disruptive variants can leave very little working enzyme, so cell processing of certain medicines and chemicals becomes less efficient.
How variants are linked to conditions
Variants in the NAT2 gene are most clearly linked to differences in drug side effect risk, especially NAT2 slow acetylator variants and liver injury from isoniazid during tuberculosis treatment. Population studies also link some NAT2 variants to a higher risk of bladder cancer, particularly in people exposed to tobacco smoke or certain workplace chemicals. These associations affect risk, not certainty, and many carriers never develop either problem.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and instead are part of natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NAT2, risk can change depending on both your gene result and what you are exposed to. Many living with slower-working NAT2 have a higher chance of side effects from some medicines, and smoking or long-term exposure to certain workplace chemicals can further raise the risk of bladder cancer. Risk still varies from person to person.
Inheritance of NAT2 variants
There is no single, broadly confirmed disease inheritance pattern for the NAT2 gene in the way seen with classic single gene conditions. Instead, how NAT2 variants are inherited is usually discussed in terms of acetylator status, a drug response trait that reflects the copy inherited from each parent. The NAT2 gene is located on chromosome 8, which is an autosome, so you inherit one NAT2 copy from your mother and one from your father. In practice, two reduced function copies are often linked to slow acetylation, while one or no reduced function copy may lead to intermediate or rapid acetylation.
What does my NAT2 result mean for my family?
There is not a broadly confirmed inherited condition for NAT2 in the way seen with single-gene conditions that clearly run in families. NAT2 results are usually used to understand how someone may process certain medicines, so what they mean for relatives depends on the exact result and the health question being considered.
Genetic information
Genetic testing
How you find out about variants
For people seeking how to test for NAT2 variants, NAT2 genetic testing uses a blood or saliva sample. A lab reads the DNA sequence of the NAT2 gene and reports which variants you carry, which can help clarify how you may process certain medicines.
When should I consider getting a genetic test?
NAT2 testing may be worth discussing before treatment with isoniazid, a medicine used for tuberculosis, because NAT2 affects how quickly your body breaks it down and this can change the chance of side effects. It can also be helpful if someone has had unusually strong side effects with certain medicines affected by NAT2.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but how much it reveals varies based on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas such as medication response, genetic results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Variants in the NAT2 gene can change how your body breaks down isoniazid, a medicine used to treat tuberculosis. Some people process this drug more slowly and may be more sensitive to side effects, while others clear it faster, which can affect drug levels in the body. This is a well-established example of how common genetic variation can help explain why the same medicine may work differently from one person to another.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape a person’s response to medications. By studying links between genes and drugs, it helps explain why the same treatment can work differently in different people. For many medicines, genes affect how strongly a drug works or how the body processes it. This understanding can support more informed and more individualized treatment decisions. If you want to explore the subject further, you can learn more in the LearnHub.
Drugs influenced by the NAT2 gene
When should I seek medical advice?
If you are about to start or change treatment for tuberculosis, it is worth asking your doctor whether NAT2 could affect how your body handles isoniazid. NAT2 can make some people break down this medicine more slowly or more quickly, which can change the chance of side effects or reduce how well treatment works. Bring it up sooner if you have had unusual reactions to this treatment before.
History
NAT2 has an important place in the history of pharmacogenetics, the study of how genes influence medicine response. In the 1950s, doctors noticed that people treated with isoniazid for tuberculosis did not all process the drug the same way. Inheritance patterns were noticed long before the gene was identified. Researchers later described “slow” and “fast” acetylators, helping show that inherited differences could shape both benefit and side effects from treatment. Building on this early work, scientists linked those patterns to the NAT2 gene, making it one of the classic examples used to explain genetic differences in drug handling. That history helped move genetics from a largely descriptive science into everyday clinical thinking about safer prescribing.